Global Ceftriaxone Sodium Market Size, Share, Trends and Forecast 2022-2030

Description

Ceftriaxone sodium is a cephalosporin antibiotic.
Industry Insights

Due to the COVID-19 pandemic, the global Ceftriaxone Sodium market size is estimated to be worth US$ 264.2 million in 2021 and is forecast to a readjusted size of US$ 217.6 million by 2028 with a CAGR of -2.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Ceftriaxone Sodium market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Ceftriaxone Sodium landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.

Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.

For the production, China and India are the mainly manufactured base.

Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.

This report focuses on Ceftriaxone Sodium volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ceftriaxone Sodium market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Ceftriaxone Sodium market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

ChP

USP

EP

Segment by Application

Single Injection

Compound Injection

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Shandong Ruiying

Qilu Antibiotics

Nectar Lifesciences

Kelun

United Laboratories

Aurobindo Pharma

Orchid Pharma

Medya Pharma

REYOUNG

LKPC

ACS Dobfar

NCPC

Dawnrays

Kopran

TABLE OF CONTENT

1 Ceftriaxone Sodium Market Overview
1.1 Product Overview and Scope of Ceftriaxone Sodium

1.2 Ceftriaxone Sodium Segment by Type

1.2.1 Global Ceftriaxone Sodium Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 ChP

1.2.3 USP

1.2.4 EP

1.3 Ceftriaxone Sodium Segment by Application

1.3.1 Global Ceftriaxone Sodium Sales Comparison by Application: (2022-2028)

1.3.2 Single Injection

1.3.3 Compound Injection

1.4 Global Ceftriaxone Sodium Market Size Estimates and Forecasts

1.4.1 Global Ceftriaxone Sodium Revenue 2017-2028

1.4.2 Global Ceftriaxone Sodium Sales 2017-2028

1.4.3 Ceftriaxone Sodium Market Size by Region: 2017 Versus 2021 Versus 2028

2 Ceftriaxone Sodium Market Competition by Manufacturers

2.1 Global Ceftriaxone Sodium Sales Market Share by Manufacturers (2017-2022)

2.2 Global Ceftriaxone Sodium Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Ceftriaxone Sodium Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Ceftriaxone Sodium Manufacturing Sites, Area Served, Product Type

2.5 Ceftriaxone Sodium Market Competitive Situation and Trends

2.5.1 Ceftriaxone Sodium Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Ceftriaxone Sodium Players Market Share by Revenue

2.5.3 Global Ceftriaxone Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ceftriaxone Sodium Retrospective Market Scenario by Region

3.1 Global Ceftriaxone Sodium Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Ceftriaxone Sodium Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Ceftriaxone Sodium Market Facts & Figures by Country

3.3.1 North America Ceftriaxone Sodium Sales by Country

3.3.2 North America Ceftriaxone Sodium Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Ceftriaxone Sodium Market Facts & Figures by Country

3.4.1 Europe Ceftriaxone Sodium Sales by Country

3.4.2 Europe Ceftriaxone Sodium Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Ceftriaxone Sodium Market Facts & Figures by Region

3.5.1 Asia Pacific Ceftriaxone Sodium Sales by Region

3.5.2 Asia Pacific Ceftriaxone Sodium Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Ceftriaxone Sodium Market Facts & Figures by Country

3.6.1 Latin America Ceftriaxone Sodium Sales by Country

3.6.2 Latin America Ceftriaxone Sodium Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Ceftriaxone Sodium Market Facts & Figures by Country

3.7.1 Middle East and Africa Ceftriaxone Sodium Sales by Country

3.7.2 Middle East and Africa Ceftriaxone Sodium Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Ceftriaxone Sodium Historic Market Analysis by Type

4.1 Global Ceftriaxone Sodium Sales Market Share by Type (2017-2022)

4.2 Global Ceftriaxone Sodium Revenue Market Share by Type (2017-2022)

4.3 Global Ceftriaxone Sodium Price by Type (2017-2022)

5 Global Ceftriaxone Sodium Historic Market Analysis by Application

5.1 Global Ceftriaxone Sodium Sales Market Share by Application (2017-2022)

5.2 Global Ceftriaxone Sodium Revenue Market Share by Application (2017-2022)

5.3 Global Ceftriaxone Sodium Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Shandong Ruiying

6.1.1 Shandong Ruiying Corporation Information

6.1.2 Shandong Ruiying Description and Business Overview

6.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Shandong Ruiying Ceftriaxone Sodium Product Portfolio

6.1.5 Shandong Ruiying Recent Developments/Updates

6.2 Qilu Antibiotics

6.2.1 Qilu Antibiotics Corporation Information

6.2.2 Qilu Antibiotics Description and Business Overview

6.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Portfolio

6.2.5 Qilu Antibiotics Recent Developments/Updates

6.3 Nectar Lifesciences

6.3.1 Nectar Lifesciences Corporation Information

6.3.2 Nectar Lifesciences Description and Business Overview

6.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Portfolio

6.3.5 Nectar Lifesciences Recent Developments/Updates

6.4 Kelun

6.4.1 Kelun Corporation Information

6.4.2 Kelun Description and Business Overview

6.4.3 Kelun Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Kelun Ceftriaxone Sodium Product Portfolio

6.4.5 Kelun Recent Developments/Updates

6.5 United Laboratories

6.5.1 United Laboratories Corporation Information

6.5.2 United Laboratories Description and Business Overview

6.5.3 United Laboratories Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.5.4 United Laboratories Ceftriaxone Sodium Product Portfolio

6.5.5 United Laboratories Recent Developments/Updates

6.6 Aurobindo Pharma

6.6.1 Aurobindo Pharma Corporation Information

6.6.2 Aurobindo Pharma Description and Business Overview

6.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Portfolio

6.6.5 Aurobindo Pharma Recent Developments/Updates

6.7 Orchid Pharma

6.6.1 Orchid Pharma Corporation Information

6.6.2 Orchid Pharma Description and Business Overview

6.6.3 Orchid Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Orchid Pharma Ceftriaxone Sodium Product Portfolio

6.7.5 Orchid Pharma Recent Developments/Updates

6.8 Medya Pharma

6.8.1 Medya Pharma Corporation Information

6.8.2 Medya Pharma Description and Business Overview

6.8.3 Medya Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Medya Pharma Ceftriaxone Sodium Product Portfolio

6.8.5 Medya Pharma Recent Developments/Updates

6.9 REYOUNG

6.9.1 REYOUNG Corporation Information

6.9.2 REYOUNG Description and Business Overview

6.9.3 REYOUNG Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.9.4 REYOUNG Ceftriaxone Sodium Product Portfolio

6.9.5 REYOUNG Recent Developments/Updates

6.10 LKPC

6.10.1 LKPC Corporation Information

6.10.2 LKPC Description and Business Overview

6.10.3 LKPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.10.4 LKPC Ceftriaxone Sodium Product Portfolio

6.10.5 LKPC Recent Developments/Updates

6.11 ACS Dobfar

6.11.1 ACS Dobfar Corporation Information

6.11.2 ACS Dobfar Ceftriaxone Sodium Description and Business Overview

6.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.11.4 ACS Dobfar Ceftriaxone Sodium Product Portfolio

6.11.5 ACS Dobfar Recent Developments/Updates

6.12 NCPC

6.12.1 NCPC Corporation Information

6.12.2 NCPC Ceftriaxone Sodium Description and Business Overview

6.12.3 NCPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.12.4 NCPC Ceftriaxone Sodium Product Portfolio

6.12.5 NCPC Recent Developments/Updates

6.13 Dawnrays

6.13.1 Dawnrays Corporation Information

6.13.2 Dawnrays Ceftriaxone Sodium Description and Business Overview

6.13.3 Dawnrays Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Dawnrays Ceftriaxone Sodium Product Portfolio

6.13.5 Dawnrays Recent Developments/Updates

6.14 Kopran

6.14.1 Kopran Corporation Information

6.14.2 Kopran Ceftriaxone Sodium Description and Business Overview

6.14.3 Kopran Ceftriaxone Sodium Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Kopran Ceftriaxone Sodium Product Portfolio

6.14.5 Kopran Recent Developments/Updates

7 Ceftriaxone Sodium Manufacturing Cost Analysis

7.1 Ceftriaxone Sodium Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Ceftriaxone Sodium

7.4 Ceftriaxone Sodium Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Ceftriaxone Sodium Distributors List

8.3 Ceftriaxone Sodium Customers

9 Ceftriaxone Sodium Market Dynamics

9.1 Ceftriaxone Sodium Industry Trends

9.2 Ceftriaxone Sodium Market Drivers

9.3 Ceftriaxone Sodium Market Challenges

9.4 Ceftriaxone Sodium Market Restraints

10 Global Market Forecast

10.1 Ceftriaxone Sodium Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Ceftriaxone Sodium by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Ceftriaxone Sodium by Type (2023-2028)

10.2 Ceftriaxone Sodium Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Ceftriaxone Sodium by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Ceftriaxone Sodium by Application (2023-2028)

10.3 Ceftriaxone Sodium Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Ceftriaxone Sodium by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Ceftriaxone Sodium by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample